Study Summary
A Clinical Study to Investigate the Safety and Efficacy of CT1390B in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Interested in this trial?
Submit an InquiryInterventions
CAR-T cells chimeric antigen receptor T cellsDRUG
CT1390B cells infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | Tianjin | China |